It was paused earlier in April after 15 vaccine recipients reported blood clotting. Dr. Steve Threlkeld, reaffirmed the safety of the vaccine, saying that individuals have a greater chance of blood clotting from COVID-19 than the Johnson & Johnson vaccine.
“You have to look at those numbers and realize it’s still way safer to get the vaccine than not get the vaccine,” said Threlkeld. Dr. Threlkeld is an infectious disease specialist at Baptist Memorial Hospital.
The cases of blood clotting were in women between the ages of 18 and 49. “People think well that’s terrible that someone can get the vaccine and die. Absolutely. It’s also terrible for someone who gets COVID and dies,” said Threlkeld.
However, Threlkeld agreed with the CDC's decision to pause the use of the vaccine. “I think probably all and all it was good to show that people are really serious about the safety of this thing,” he said.
“If I were a woman age 39 and had all three vaccines available to me and I had to pick one it might be a reasonable choice to take one of the other vaccines, it’s not a reasonable choice to have that be the only vaccine available and choose not to get it,” he added.
He suggests women in the age range that reported blood clotting do their research and consider the Pfizer or Moderna vaccine.